Indian Immunologicals likely to start Covaxin production in a month
This plant would make an additional six million units of the Covaxin. Indian Immunologicals (IIL), a public sector enterprise, will start manufacturing and supplying Covid-19 vaccines by the end of August or early September from its facility in Hyderabad. This would augment production of Bharat Biotech’s Covaxin vaccine in the country. V K Paul, member, … Read more